Colin Marsh
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Research top 5%
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Adrian L. HarrisDavid E. NealR R HallM. BennettJ R C SainsburyMary RobinsonD VealeT Ashcroft
- Journals
- British Journal of Cancer (3 papers)The Journal of Urology (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)The Prostate (1 paper)Histopathology (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Colin Marsh
18 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 675
- Cancer Research 332
- Pulmonary and Respiratory Medicine 542
- Molecular Biology 732
- Radiology, Nuclear Medicine and Imaging 205
Countries citing papers authored by Colin Marsh
This map shows the geographic impact of Colin Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Marsh more than expected).
Fields of papers citing papers by Colin Marsh
This network shows the impact of papers produced by Colin Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Marsh. The network helps show where Colin Marsh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Colin Marsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 66 | |
| 2 | Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer. | 2003 | 37 |
| 3 | 2002 | 75 | |
| 4 | 2001 | 21 | |
| 5 | 1999 | 124 | |
| 6 | 1999 | 52 | |
| 7 | 1999 | 1 | |
| 8 | TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer. | 1999 | 30 |
| 9 | Chemotherapy and muscle-invasive bladder cancer: Assessment of p53 immuno-reactivity (IR) as a predictor of response | 1998 | 1 |
| 10 | 1998 | 77 | |
| 11 | 1992 | 55 | |
| 12 | 1992 | 134 | |
| 13 | 1990 | 39 | |
| 14 | 1987 | 10 | |
| 15 | 1987 | 11 | |
| 16 | 1987 | 271 | |
| 17 | RECEPTORS FOR EPIDERMAL GROWTH-FACTOR ARE PRESENT ON HUMAN BLADDER-TUMORS | 1985 | 1 |
| 18 | EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS Hit paper breakdown → | 1985 | 522 |
About Colin Marsh
Colin Marsh is a scholar working on Oncology, Cancer Research, Biotechnology, Cell Biology and Surgery, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Fibroblast Growth Factor Research (3 papers), Urinary and Genital Oncology Studies (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Cancer Research and Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers), Connective tissue disorders research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (675 citations), Cancer Research (332 citations), Pulmonary and Respiratory Medicine (542 citations), Molecular Biology (732 citations) and Radiology, Nuclear Medicine and Imaging (205 citations). Colin Marsh has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Adrian L. Harris, David E. Neal, R R Hall, M. Bennett, J R C Sainsbury, Mary Robinson, D Veale, T Ashcroft, G J Gibson and Hing Y. Leung. Their work appears in journals such as British Journal of Cancer, The Journal of Urology, International Journal of Radiation Oncology*Biology*Physics, The Prostate and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.